Genocea Biosciences, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (40)

View All

Latest Posts

About This Stock More About This Stock
US Stock Market Weekly Review July 20-24
Article By: Stavros Georgiadis
Sunday, July 26, 2020 10:50 PM EDT
It was a week with moderate losses for the US stock market amid important earnings reports and new political tensions between the USA and China.
In this article: RNET, GNCA Also: INTC, AMD
Read
Weighing The Week Ahead: Chinese Fireworks?
Article By: Jeff Miller
Sunday, June 30, 2019 11:27 AM EDT
The combination of events, data, and the calendar make the week ahead even murkier than usual. I expect an initial focus on the US/China trade truce, a shift to discussion of the implications for Fed policy, and a fast exit for the beach.
In this article: STAG, ABBV, GNCA, SJM, VTR
Read
Genocea Biosciences, Inc. Shares Crash As Company Announces Layoffs & Shift In Drug Development Strategy
Article By: TickerTV
Wednesday, September 27, 2017 11:36 AM EDT
GNCA opened trading yesterday at $5.24 which was down from the previous day’s trading close of $5.29. Shares closed trading yesterday at $5.33 and spiked down aftermarket to $2.70, equivalent to a 49% decrease from the closing price.
In this article: GNCA
Read
How To Find Winning Biotech Stocks
Article By: Tracey Ryniec
Monday, April 11, 2016 7:57 AM EDT
If you want to improve your odds of owning a biotech company with a viable drug that it eventually can sell to patients, you should be buying in after the company has passed several of the phases of drug development.
In this article: MACK, JUNO, GNCA Also: BBC
Read
Shares Of Genocea Soar 94% After Positive Phase 2 Herpes Results
Article By: Terry Chrisomalis
Thursday, March 31, 2016 6:41 PM EDT
The company's genital herpes vaccine posted positive results, and Cowen rates the stock Outperform.
In this article: GNCA
Read
All Posts

Latest Tweets for $GNCA

No tweets yet!

PARTNER HEADLINES